We are pleased to share a selection of papers published in 2024 on the topic of “Advancing the Management of Hepatocellular Carcinoma”, in the journal Cancers (ISSN: 2072-6694). Below is a list of high-quality articles that we believe you will find insightful and engaging.
1. “Hepatocellular Carcinoma: Current Drug Therapeutic Status, Advances and Challenges”
by Shunzhen Zheng, Siew Wee Chan, Fei Liu, Jun Liu, Pierce Kah Hoe Chow, Han Chong Toh and Wanjin Hong
Cancers 2024, 16(8), 1582; https://doi.org/10.3390/cancers16081582
Available online: https://www.mdpi.com/2072-6694/16/8/1582
2. “Metabolic Dysfunction-Associated Steatohepatitis and Progression to Hepatocellular Carcinoma: A Literature Review”
by Haider Ghazanfar, Nismat Javed, Abeer Qasim, George Sarin Zacharia, Ali Ghazanfar, Abhilasha Jyala, Elona Shehi and Harish Patel
Cancers 2024, 16(6), 1214; https://doi.org/10.3390/cancers16061214
Available online: https://www.mdpi.com/2072-6694/16/6/1214
3. “Machine Learning-Based Assessment of Survival and Risk Factors in Non-Alcoholic Fatty Liver Disease-Related Hepatocellular Carcinoma for Optimized Patient Management”
by Miguel Suárez, Sergio Gil-Rojas, Pablo Martínez-Blanco, Ana M. Torres, Antonio Ramón, Pilar Blasco-Segura, Miguel Torralba and Jorge Mateo
Cancers 2024, 16(6), 1114; https://doi.org/10.3390/cancers16061114
Available online: https://www.mdpi.com/2072-6694/16/6/1114
4. “Management of Hepatocellular Carcinoma in 2024: The Multidisciplinary Paradigm in an Evolving Treatment Landscape”
by Emily Kinsey and Hannah M. Lee
Cancers 2024, 16(3), 666; https://doi.org/10.3390/cancers16030666
Available online: https://www.mdpi.com/2072-6694/16/3/666
5. “Hepatocellular Carcinoma: Old and Emerging Therapeutic Targets”
by Greta Pessino, Claudia Scotti, Maristella Maggi and Immuno-HUB Consortium
Cancers 2024, 16(5), 901; https://doi.org/10.3390/cancers16050901
Available online: https://www.mdpi.com/2072-6694/16/5/901
6. “Transarterial Chemoembolization Treatment Paradigms for Hepatocellular Carcinoma”
by Elliott L. Fite and Mina S. Makary
Cancers 2024, 16(13), 2430; https://doi.org/10.3390/cancers16132430
Available online: https://www.mdpi.com/2072-6694/16/13/2430
7. “Immune Checkpoint Inhibitors in Hepatocellular Carcinoma and Their Hepatic-Related Side Effects: A Review”
by Thomas M. Ruli Jr., Ethan D. Pollack, Atul Lodh, Charles D. Evers III, Christopher A. Price and Mohamed Shoreibah
Cancers 2024, 16(11), 2042; https://doi.org/10.3390/cancers16112042
Available online: https://www.mdpi.com/2072-6694/16/11/2042
8. “Transarterial Radioembolization (TARE) in Patients with Hepatocellular Carcinoma: A Comparison of Palliative with Bridging-to-Transplant Concepts”
by Jacqueline Schönherr, Philipp Seifert, Falk Gühne, Thomas Winkens, Falk Rauchfuß, Utz Settmacher, Martin Freesmeyer and Robert Drescher
Cancers 2024, 16(1), 235; https://doi.org/10.3390/cancers16010235
Available online: https://www.mdpi.com/2072-6694/16/1/235
You can view and submit relevant papers to Cancers via https://www.mdpi.com/journal/cancers.
Cancers Editorial Office
